Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Beginning Cash Balance: 2011-2025

Historic Beginning Cash Balance for Sonoma Pharmaceuticals (SNOA) over the last 14 years, with Mar 2025 value amounting to -$2.2 million.

  • Sonoma Pharmaceuticals' Beginning Cash Balance fell 126.24% to -$1.3 million in Q1 2013 from the same period last year, while for Mar 2013 it was -$4.5 million, marking a year-over-year decrease of 204.07%. This contributed to the annual value of -$2.2 million for FY2025, which is 424.57% down from last year.
  • Per Sonoma Pharmaceuticals' latest filing, its Beginning Cash Balance stood at -$2.2 million for FY2025, which was down 424.57% from $692,000 recorded in FY2024.
  • In the past 5 years, Sonoma Pharmaceuticals' Beginning Cash Balance registered a high of $3.6 million during FY2023, and its lowest value of -$3.2 million during FY2022.
  • Over the past 3 years, Sonoma Pharmaceuticals' median Beginning Cash Balance value was $692,000 (recorded in 2024), while the average stood at $674,000.
  • As far as peak fluctuations go, Sonoma Pharmaceuticals' Beginning Cash Balance plummeted by 26,350.00% in 2021, and later skyrocketed by 212.59% in 2023.
  • Over the past 5 years, Sonoma Pharmaceuticals' Beginning Cash Balance (Yearly) stood at -$529,000 in 2021, then plummeted by 500.38% to -$3.2 million in 2022, then spiked by 212.59% to $3.6 million in 2023, then slumped by 80.65% to $692,000 in 2024, then slumped by 424.57% to -$2.2 million in 2025.